...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture
【24h】

Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture

机译:单次阳性血液培养患者革兰阳性COCC1的快速聚合酶链反应的生物鉴定评价

获取原文
获取原文并翻译 | 示例
           

摘要

For patients with a single-positive blood culture growing gram-positive cocci, organism identification can provide supportive information for differentiating contamination from infection. We investigated the effect of a rapid blood culture identification panel (BCID) on vancomycin-prescribing patterns and patient outcomes for single positive blood culture (PBC) growing gram-positive cocci. Adult patients with single-positive blood culture growing gram-positive cocci with conventional organism identification (pre-BCID) were compared with organism identification by BCID (post-BCID). Antimicrobial Stewardship Program (ASP) review of PBC was performed in both study groups. Vancomycin prescribing patterns were studied. Secondary endpoints were the incidence of nephrotoxicity, length of stay (LOS), readmission rate, mortality, and hospital costs. A total of 188 patients (86 pre-BCID, 102 post-BCID) were included. Organism identification was known 21 h sooner in the post-BCID group (P < 0.001). Coagulase-negative staphylococci were the most commonly isolated organisms (73%). In patients where vancomycin was deemed unnecessary (n = 133), vancomycin use (51% pre-BCID vs 36% post-BCID; P = 0.09) and time from culture positivity to vancomycin discontinuation (1.5 vs. 1.7 days; P = 0.92) did not differ between groups. We found no differences in the development of nephrotoxicity, LOS, readmission, mortality, or hospital costs. Earlier identification of single positive blood culture growing gram-positive cocci did not significantly influence prescribing patterns of vancomycin. However, baseline antimicrobial stewardship review of single positive blood culture growing gram-positive cocci may have lessened the opportunity for detectable differences. Larger studies, accounting for the impact of ASP intervention, should be performed to determine the value of each individual component.
机译:对于患有单阳性血液培养的患者生长革兰氏阳性COCC1,可以提供用于区分感染污染的支持性信息。我们调查了一种快速血液培养鉴定面板(BCID)对单一阳性血液培养(PBC)生长革兰阳性COCC1的血症处方模式和患者结果的影响。将具有常规生物鉴定的单阳性血液培养的成年患者生长革兰氏阳性COCC1与BCID(后BCID后的生物体鉴定进行比较。两项研究组进行了对PBC的抗微生物管道(ASP)审查。研究了万古霉素处方模式。次要终点是肾毒性,住院时间长度(LOS),入院率,死亡率和医院成本的发生率。还包括188名患者(86例预生物,102个后BCID)。在BCID后21小时内已知生物体鉴定(P <0.001)。凝固酶阴性葡萄球菌是最常见的生物(73%)。在患者中认为不需要的(n = 133),万古霉素使用(51%前BCID与BCID后36%的36%)和从培养阳性到万古霉素停止(1.5 Vs.1.7天; P = 0.92 )组之间没有差异。我们发现肾毒性,洛杉矶,阅览,死亡率或医院费用没有差异。早期鉴定单一阳性血液培养生长革兰氏阳性COCC1并未显着影响万古霉素的规定模式。然而,基线抗微生物管道审查对单一阳性血液培养生长革兰氏阳性COCCI的审查可能会减少可检测到的差异的机会。应进行较大的研究,核算ASP干预的影响,以确定每个单独组分的值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号